Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesIntramuscular Haloperidol versus Intramuscular Olanzapine for Treatment of Acute Agitation: A Cost-Minimization Study
Pharmacotherapy, 07/31/09
Freeman DJ et al. – For the treatment of acute episodes of agitation, regimens based on intramuscular haloperidol were significantly less expensive than and at least as effective as those based on intramuscular olanzapine.
Related Articles
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
British Journal of Psychiatry, 11/12/09
Relevance Score: 88%
Maternal schizophrenia and pregnancy outcome: Does the use of antipsychotics make a difference
Schizophrenia Research, 11/12/09
Relevance Score: 87%
Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients
European Psychiatry, 11/06/09
Relevance Score: 87%
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Relevance Score: 87%
Antipsychotic effects on auditory sensory gating in schizophrenia patients
European Neuropsychopharmacology, 10/21/09
Relevance Score: 87%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Functional Magnetic Resonance Imaging of Effects of a Nicotinic Agonist in Schizophrenia
Neuropsychopharmacology, 12/15/09
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology, 12/15/09
An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas
Journal of Pharmacy and Pharmacology, 12/15/09
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Cost-effectiveness of single agent, uptitration and switching statin treatment strategies for lipid lowering in Sweden
Current Medical Research and Opinion, 12/14/09
Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin
Current Medical Research and Opinion, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor